33 Chimerix's (CMRX) recently approved "weaponized smallpox" vaccine (Brincidofovir) has previously failed TWO different Phase 3 trials with all-cause deaths in the treatment group occurring at 150% of the rate for placebo group, 15% versus 10%. (www.fiercebiotech.com) posted 3 years ago by Error_usernotfound 3 years ago by Error_usernotfound +33 / -0 8 comments share 8 comments share save hide report block hide replies
So this stock is a buy buy buy?